Management of Arterial Vasospasm Following Aneurysmal Subarachnoid Hemorrhage

Abstract

Despite recent advances, cerebral vasospasm and delayed cerebral ischemia (DCI) still represent a major cause of morbidity and mortality following aneurysmal subarachnoid hemorrhage (aSAH). Although a significant portion of the morbidity and mortality associated with aSAH is related to the initial hemorrhagic ictus, cerebral vasospasm and DCI are still the leading cause of poor outcomes and death in the acute posthemorrhage period, causing long-term disability or death in more than one in five of all patients who have suffered aSAH and initially survived.

Management of patients following aSAH includes four major considerations: (1) prediction of patients at highest risk for development of DCI, (2) prophylactic measures to reduce its occurrence, (3) monitoring to detect early signs of cerebral ischemia, and (4) treatments to correct vasospasm and cerebral ischemia once it occurs. The authors review the pertinent literature related to each, including both the current management guidelines supported by the literature as well as novel management strategies that are currently being investigated.

Keywords

vasospasm - subarachnoid hemorrhage - stroke - delayed cerebral ischemia

• References

• 1 Becker KJ. Epidemiology and clinical presentation of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am 1998; 9 (3) 435-444
• 2 Wardlaw JM, White PM. The detection and management of unruptured intracranial aneurysms. Brain 2000; 123 (Pt 2): 205-221
• 3 Dombovy ML, Drew-Cates J, Serdans R. Recovery and rehabilitation following subarachnoid haemorrhage. Part I: Outcome after inpatient rehabilitation. Brain Inj 1998; 12 (6) 443-454
• 4 Lee WC, Christensen MC, Joshi AV, Pashos CL. Long-term cost of stroke subtypes among Medicare beneficiaries. Cerebrovasc Dis 2007; 23 (1) 57-65
• 5 Wilkins RH. Cerebral vasospasm. Crit Rev Neurobiol 1990; 6 (1) 51-77
• 6 Dorsch NW. Cerebral arterial spasm—a clinical review. Br J Neurosurg 1995; 9 (3) 403-412
• 7 Dorsch NW, King MT. A review of cerebral vasospasm in aneurysmal subarachnoid haemorrhage Part I: Incidence and effects. J Clin Neurosci 1994; 1 (1) 19-26
• 8 Fergusen S, Macdonald RL. Predictors of cerebral infarction in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 2007; 60 (4) 658-667 , discussion 667
• 9 Broderick JP, Brott TG, Duldner JE, Tomsick T, Leach A. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage. Stroke 1994; 25 (7) 1342-1347
• 10 Kassell NF, Torner JC, Haley Jr EC, Jane JA, Adams HP, Kongable GL. The International Cooperative Study on the Timing of Aneurysm Surgery. Part 1: Overall management results. J Neurosurg 1990; 73 (1) 18-36
• 11 Proust F, Hannequin D, Langlois O, Freger P, Creissard P. Causes of morbidity and mortality after ruptured aneurysm surgery in a series of 230 patients. The importance of control angiography. Stroke 1995; 26 (9) 1553-1557
• 12 Zabramski J, Hamilton MG. Cerebral Vasospasm. In: Spetzler RF, , ed. Neurovascular Surgery. New York, NY: McGraw-Hill; 1994
• 13 Weir B, Macdonald RL, Stoodley M. Etiology of cerebral vasospasm. Acta Neurochir Suppl (Wien) 1999; 72: 27-46
• 14 Weir B, Grace M, Hansen J, Rothberg C. Time course of vasospasm in man. J Neurosurg 1978; 48 (2) 173-178
• 15 Macdonald RL, Kassell NF, Mayer S , et al; CONSCIOUS-1 Investigators. Clazosentan to overcome neurological ischemia and infarction occurring after subarachnoid hemorrhage (CONSCIOUS-1): randomized, double-blind, placebo-controlled phase 2 dose-finding trial. Stroke 2008; 39 (11) 3015-3021
• 16 Petruk KC, West M, Mohr G , et al. Nimodipine treatment in poor-grade aneurysm patients. Results of a multicenter double-blind placebo-controlled trial. J Neurosurg 1988; 68 (4) 505-517
• 17 Rinkel GJ, Feigin VL, Algra A, van den Bergh WM, Vermeulen M, van Gijn J. Calcium antagonists for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2005; (1) CD000277
• 18 Macdonald RL, Pluta RM, Zhang JH. Cerebral vasospasm after subarachnoid hemorrhage: the emerging revolution. Nat Clin Pract Neurol 2007; 3 (5) 256-263
• 19 Bederson JB, Levy AL, Ding WH , et al. Acute vasoconstriction after subarachnoid hemorrhage. Neurosurgery 1998; 42 (2) 352-360
• 20 Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia. Part I: Pathophysiology. J Neurosurg 1992; 77 (2) 169-184
• 21 Asano T, Sano K. Pathogenetic role of no-reflow phenomenon in experimental subarachnoid hemorrhage in dogs. J Neurosurg 1977; 46 (4) 454-466
• 22 Hadeishi H, Suzuki A, Yasui N, Hatazawa J, Shimosegawa E. Diffusion-weighted magnetic resonance imaging in patients with subarachnoid hemorrhage. Neurosurgery 2002; 50 (4) 741-747 , discussion 747–748
• 23 Hamann GF, Okada Y, Fitridge R, del Zoppo GJ. Microvascular basal lamina antigens disappear during cerebral ischemia and reperfusion. Stroke 1995; 26 (11) 2120-2126
• 24 Uhl E, Lehmberg J, Steiger HJ, Messmer K. Intraoperative detection of early microvasospasm in patients with subarachnoid hemorrhage by using orthogonal polarization spectral imaging. Neurosurgery 2003; 52 (6) 1307-1315
• 25 Harada S, Kamiya K, Masago A, Iwata A, Yamada K. Subarachnoid hemorrhage induces c-fos, c-jun and hsp70 mRNA expression in rat brain. Neuroreport 1997; 8 (15) 3399-3404
• 26 Kawamura Y, Yamada K, Masago A, Katano H, Matsumoto T, Mase M. Hypothermia modulates induction of hsp70 and c-jun mRNA in the rat brain after subarachnoid hemorrhage. J Neurotrauma 2000; 17 (3) 243-250
• 27 Marzatico F, Gaetani P, Rodriguez y Baena R, Silvani V, Paoletti P, Benzi G. Bioenergetics of different brain areas after experimental subarachnoid hemorrhage in rats. Stroke 1988; 19 (3) 378-384
• 28 Marzatico F, Gaetani P, Silvani V, Lombardi D, Sinforiani E, Rodriguez y Baena R. Experimental isobaric subarachnoid hemorrhage: regional mitochondrial function during the acute and late phase. Surg Neurol 1990; 34 (5) 294-300
• 29 Matz P, Turner C, Weinstein PR, Massa SM, Panter SS, Sharp FR. Heme-oxygenase-1 induction in glia throughout rat brain following experimental subarachnoid hemorrhage. Brain Res 1996; 713 (1-2) 211-222
• 30 Nilsson OG, Säveland H, Boris-Möller F, Brandt L, Wieloch T. Increased levels of glutamate in patients with subarachnoid haemorrhage as measured by intracerebral microdialysis. Acta Neurochir Suppl (Wien) 1996; 67: 45-47
• 31 Peerdeman SM, van Tulder MW, Vandertop WP. Cerebral microdialysis as a monitoring method in subarachnoid hemorrhage patients, and correlation with clinical events—a systematic review. J Neurol 2003; 250 (7) 797-805
• 32 Sarrafzadeh AS, Sakowitz OW, Kiening KL, Benndorf G, Lanksch WR, Unterberg AW. Bedside microdialysis: a tool to monitor cerebral metabolism in subarachnoid hemorrhage patients?. Crit Care Med 2002; 30 (5) 1062-1070
• 33 Säveland H, Nilsson OG, Boris-Möller F, Wieloch T, Brandt L. Intracerebral microdialysis of glutamate and aspartate in two vascular territories after aneurysmal subarachnoid hemorrhage. Neurosurgery 1996; 38 (1) 12-19 , discussion 19–20
• 34 Wang X, Marton LS, Weir BK, Macdonald RL. Immediate early gene expression in vascular smooth-muscle cells synergistically induced by hemolysate components. J Neurosurg 1999; 90 (6) 1083-1090
• 35 Takeuchi H, Handa Y, Kobayashi H, Kawano H, Hayashi M. Impairment of cerebral autoregulation during the development of chronic cerebral vasospasm after subarachnoid hemorrhage in primates. Neurosurgery 1991; 28 (1) 41-48
• 36 Yundt KD, Grubb Jr RL, Diringer MN, Powers WJ. Autoregulatory vasodilation of parenchymal vessels is impaired during cerebral vasospasm. J Cereb Blood Flow Metab 1998; 18 (4) 419-424
• 37 Gonzalez NR, Boscardin WJ, Glenn T, Vinuela F, Martin NA. Vasospasm probability index: a combination of transcranial Doppler velocities, cerebral blood flow, and clinical risk factors to predict cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2007; 107 (6) 1101-1112
• 38 Toi H, Matsumoto N, Yokosuka K, Matsubara S, Hirano K, Uno M. Prediction of cerebral vasospasm using early stage transcranial Doppler. Neurol Med Chir (Tokyo) 2013; 53 (6) 396-402
• 39 Friedman JA, Goerss SJ, Meyer FB , et al. Volumetric quantification of Fisher grade 3 aneurysmal subarachnoid hemorrhage: a novel method to predict symptomatic vasospasm on admission computerized tomography scans. J Neurosurg 2002; 97 (2) 401-407
• 40 Reilly C, Amidei C, Tolentino J, Jahromi BS, Macdonald RL. Clot volume and clearance rate as independent predictors of vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 101 (2) 255-261
• 41 Kramer AH, Hehir M, Nathan B , et al. A comparison of 3 radiographic scales for the prediction of delayed ischemia and prognosis following subarachnoid hemorrhage. J Neurosurg 2008; 109 (2) 199-207
• 42 Harrod CG, Bendok BR, Batjer HH. Prediction of cerebral vasospasm in patients presenting with aneurysmal subarachnoid hemorrhage: a review. Neurosurgery 2005; 56 (4) 633-654 , discussion 633–654
• 43 Conway JE, Tamargo RJ. Cocaine use is an independent risk factor for cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2001; 32 (10) 2338-2343
• 44 Mocco J, Ransom ER, Komotar RJ , et al. Racial differences in cerebral vasospasm: a systematic review of the literature. Neurosurgery 2006; 58 (2) 305-314
• 45 Rabinstein AA, Pichelmann MA, Friedman JA , et al. Symptomatic vasospasm and outcomes following aneurysmal subarachnoid hemorrhage: a comparison between surgical repair and endovascular coil occlusion. J Neurosurg 2003; 98 (2) 319-325
• 46 Connolly Jr ES, Rabinstein AA, Carhuapoma JR , et al; American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Cardiovascular Nursing; Council on Cardiovascular Surgery and Anesthesia; Council on Clinical Cardiology. Guidelines for the management of aneurysmal subarachnoid hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2012; 43 (6) 1711-1737
• 47 Aaslid R, Markwalder TM, Nornes H. Noninvasive transcranial Doppler ultrasound recording of flow velocity in basal cerebral arteries. J Neurosurg 1982; 57 (6) 769-774
• 48 Lindegaard KF, Nornes H, Bakke SJ, Sorteberg W, Nakstad P. Cerebral vasospasm diagnosis by means of angiography and blood velocity measurements. Acta Neurochir (Wien) 1989; 100 (1-2) 12-24
• 49 Condette-Auliac S, Bracard S, Anxionnat R , et al. Vasospasm after subarachnoid hemorrhage: interest in diffusion-weighted MR imaging. Stroke 2001; 32 (8) 1818-1824
• 50 Egge A, Sjøholm H, Waterloo K, Solberg T, Ingebrigtsen T, Romner B. Serial single-photon emission computed tomographic and transcranial Doppler measurements for evaluation of vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery 2005; 57 (2) 237-242 , discussion 237–242
• 51 Hertel F, Walter C, Bettag M, Mörsdorf M. Perfusion-weighted magnetic resonance imaging in patients with vasospasm: a useful new tool in the management of patients with subarachnoid hemorrhage. Neurosurgery 2005; 56 (1) 28-35 , discussion 35
• 52 Minhas PS, Menon DK, Smielewski P , et al. Positron emission tomographic cerebral perfusion disturbances and transcranial Doppler findings among patients with neurological deterioration after subarachnoid hemorrhage. Neurosurgery 2003; 52 (5) 1017-1022
• 53 Sviri GE, Britz GW, Lewis DH, Newell DW, Zaaroor M, Cohen W. Dynamic perfusion computed tomography in the diagnosis of cerebral vasospasm. Neurosurgery 2006; 59 (2) 319-325 , discussion 319–325
• 54 van der Schaaf I, Wermer MJ, van der Graaf Y, Velthuis BK, van de Kraats CI, Rinkel GJ. Prognostic value of cerebral perfusion-computed tomography in the acute stage after subarachnoid hemorrhage for the development of delayed cerebral ischemia. Stroke 2006; 37 (2) 409-413
• 55 Weidauer S, Lanfermann H, Raabe A, Zanella F, Seifert V, Beck J. Impairment of cerebral perfusion and infarct patterns attributable to vasospasm after aneurysmal subarachnoid hemorrhage: a prospective MRI and DSA study. Stroke 2007; 38 (6) 1831-1836
• 56 Vajkoczy P, Horn P, Thome C, Munch E, Schmiedek P. Regional cerebral blood flow monitoring in the diagnosis of delayed ischemia following aneurysmal subarachnoid hemorrhage. J Neurosurg 2003; 98 (6) 1227-1234
• 57 Unterberg AW, Sakowitz OW, Sarrafzadeh AS, Benndorf G, Lanksch WR. Role of bedside microdialysis in the diagnosis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 2001; 94 (5) 740-749
• 58 Kett-White R, Hutchinson PJ, Al-Rawi PG, Gupta AK, Pickard JD, Kirkpatrick PJ. Adverse cerebral events detected after subarachnoid hemorrhage using brain oxygen and microdialysis probes. Neurosurgery 2002; 50 (6) 1213-1221
• 59 Skjøth-Rasmussen J, Schulz M, Kristensen SR, Bjerre P. Delayed neurological deficits detected by an ischemic pattern in the extracellular cerebral metabolites in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 2004; 100 (1) 8-15
• 60 Rathakrishnan R, Gotman J, Dubeau F, Angle M. Using continuous electroencephalography in the management of delayed cerebral ischemia following subarachnoid hemorrhage. Neurocrit Care 2011; 14 (2) 152-161
• 61 Heran NS, Hentschel SJ, Toyota BD. Jugular bulb oximetry for prediction of vasospasm following subarachnoid hemorrhage. Can J Neurol Sci 2004; 31 (1) 80-86
• 62 Yokose N, Sakatani K, Murata Y , et al. Bedside monitoring of cerebral blood oxygenation and hemodynamics after aneurysmal subarachnoid hemorrhage by quantitative time-resolved near-infrared spectroscopy. World Neurosurg 2010; 73 (5) 508-513
• 63 Mutoh T, Ishikawa T, Suzuki A, Yasui N. Continuous cardiac output and near-infrared spectroscopy monitoring to assist in management of symptomatic cerebral vasospasm after subarachnoid hemorrhage. Neurocrit Care 2010; 13 (3) 331-338
• 64 Nakagawa A, Su CC, Sato K, Shirane R. Evaluation of changes in circulating blood volume during acute and very acute stages of subarachnoid hemorrhage: implications for the management of hypovolemia. J Neurosurg 2002; 97 (2) 268-271
• 65 Egge A, Waterloo K, Sjøholm H, Solberg T, Ingebrigtsen T, Romner B. Prophylactic hyperdynamic postoperative fluid therapy after aneurysmal subarachnoid hemorrhage: a clinical, prospective, randomized, controlled study. Neurosurgery 2001; 49 (3) 593-605
• 66 Lennihan L, Mayer SA, Fink ME , et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke 2000; 31 (2) 383-391
• 67 Treggiari MM, Walder B, Suter PM, Romand JA. Systematic review of the prevention of delayed ischemic neurological deficits with hypertension, hypervolemia, and hemodilution therapy following subarachnoid hemorrhage. J Neurosurg 2003; 98 (5) 978-984
• 68 Lynch JR, Wang H, McGirt MJ , et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke 2005; 36 (9) 2024-2026
• 69 Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke 2005; 36 (8) 1627-1632
• 70 Tseng MY, Hutchinson PJ, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute pravastatin treatment on intensity of rescue therapy, length of inpatient stay, and 6-month outcome in patients after aneurysmal subarachnoid hemorrhage. Stroke 2007; 38 (5) 1545-1550
• 71 Vergouwen MD, Meijers JC, Geskus RB , et al. Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial. J Cereb Blood Flow Metab 2009; 29 (8) 1444-1453
• 72 Tseng MY ; Participants in the International Multidisciplinary Consensus Conference on the Critical Care Management of Subarachnoid Hemorrhage. Summary of evidence on immediate statins therapy following aneurysmal subarachnoid hemorrhage. Neurocrit Care 2011; 15 (2) 298-301
• 73 Macdonald RL, Higashida RT, Keller E , et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol 2011; 10 (7) 618-625
• 74 Macdonald RL, Higashida RT, Keller E , et al. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke 2012; 43 (6) 1463-1469
• 75 Wong GK, Poon WS, Chan MT , et al; IMASH Investigators. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Stroke 2010; 41 (5) 921-926
• 76 Veyna RS, Seyfried D, Burke DG , et al. Magnesium sulfate therapy after aneurysmal subarachnoid hemorrhage. J Neurosurg 2002; 96 (3) 510-514
• 77 Stippler M, Crago E, Levy EI , et al. Magnesium infusion for vasospasm prophylaxis after subarachnoid hemorrhage. J Neurosurg 2006; 105 (5) 723-729
• 78 Schmid-Elsaesser R, Kunz M, Zausinger S, Prueckner S, Briegel J, Steiger HJ. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study. Neurosurgery 2006; 58 (6) 1054-1065 , discussion 1054–1065
• 79 Zhao XD, Zhou YT, Zhang X, Zhuang Z, Shi JX. A meta analysis of treating subarachnoid hemorrhage with magnesium sulfate. J Clin Neurosci 2009; 16 (11) 1394-1397
• 80 Kawamoto S, Tsutsumi K, Yoshikawa G , et al. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2004; 100 (2) 236-243
• 81 Kramer AH, Fletcher JJ. Locally-administered intrathecal thrombolytics following aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis. Neurocrit Care 2011; 14 (3) 489-499
• 82 Amin-Hanjani S, Ogilvy CS, Barker II FG. Does intracisternal thrombolysis prevent vasospasm after aneurysmal subarachnoid hemorrhage? A meta-analysis. Neurosurgery 2004; 54 (2) 326-334
• 83 Hänggi D, Liersch J, Turowski B, Yong M, Steiger HJ. The effect of lumboventricular lavage and simultaneous low-frequency head-motion therapy after severe subarachnoid hemorrhage: results of a single center prospective Phase II trial. J Neurosurg 2008; 108 (6) 1192-1199
• 84 Klimo Jr P, Kestle JR, MacDonald JD, Schmidt RH. Marked reduction of cerebral vasospasm with lumbar drainage of cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 2004; 100 (2) 215-224
• 85 Andaluz N, Zuccarello M. Fenestration of the lamina terminalis as a valuable adjunct in aneurysm surgery. Neurosurgery 2004; 55 (5) 1050-1059
• 86 Dalbasti T, Karabiyikoglu M, Ozdamar N, Oktar N, Cagli S. Efficacy of controlled-release papaverine pellets in preventing symptomatic cerebral vasospasm. J Neurosurg 2001; 95 (1) 44-50
• 87 Kasuya H, Onda H, Sasahara A, Takeshita M, Hori T. Application of nicardipine prolonged-release implants: analysis of 97 consecutive patients with acute subarachnoid hemorrhage. Neurosurgery 2005; 56 (5) 895-902 , discussion 895–902
• 88 Zwienenberg-Lee M, Hartman J, Rudisill N , et al; Balloon Prophylaxis for Aneurysmal Vasospasm (BPAV) Study Group. Effect of prophylactic transluminal balloon angioplasty on cerebral vasospasm and outcome in patients with Fisher grade III subarachnoid hemorrhage: results of a phase II multicenter, randomized, clinical trial. Stroke 2008; 39 (6) 1759-1765
• 89 Dorhout Mees SM, van den Bergh WM, Algra A, Rinkel GJ. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage. Cochrane Database Syst Rev 2007; (4) CD006184
• 90 Jost SC, Diringer MN, Zazulia AR , et al. Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage. J Neurosurg 2005; 103 (1) 25-30
• 91 Dankbaar JW, Slooter AJ, Rinkel GJ, Schaaf IC. Effect of different components of triple-H therapy on cerebral perfusion in patients with aneurysmal subarachnoid haemorrhage: a systematic review. Crit Care 2010; 14 (1) R23
• 92 Miller JA, Dacey Jr RG, Diringer MN. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Stroke 1995; 26 (12) 2260-2266
• 93 Amin-Hanjani S, Schwartz RB, Sathi S, Stieg PE. Hypertensive encephalopathy as a complication of hyperdynamic therapy for vasospasm: report of two cases. Neurosurgery 1999; 44 (5) 1113-1116
• 94 Hoh BL, Carter BS, Ogilvy CS. Risk of hemorrhage from unsecured, unruptured aneurysms during and after hypertensive hypervolemic therapy. Neurosurgery 2002; 50 (6) 1207-1211
• 95 Raabe A, Beck J, Keller M, Vatter H, Zimmermann M, Seifert V. Relative importance of hypertension compared with hypervolemia for increasing cerebral oxygenation in patients with cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg 2005; 103 (6) 974-981
• 96 Jun P, Ko NU, English JD , et al. Endovascular treatment of medically refractory cerebral vasospasm following aneurysmal subarachnoid hemorrhage. AJNR Am J Neuroradiol 2010; 31 (10) 1911-1916
• 97 Terry A, Zipfel G, Milner E , et al. Safety and technical efficacy of over-the-wire balloons for the treatment of subarachnoid hemorrhage-induced cerebral vasospasm. Neurosurg Focus 2006; 21 (3) E14
• 98 Smith WS, Dowd CF, Johnston SC , et al. Neurotoxicity of intra-arterial papaverine preserved with chlorobutanol used for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2004; 35 (11) 2518-2522
• 99 Keuskamp J, Murali R, Chao KH. High-dose intraarterial verapamil in the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg 2008; 108 (3) 458-463
• 100 Tanaka K, Minami H, Kota M, Kuwamura K, Kohmura E. Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride. Neurosurgery 2005; 56 (2) 214-223 , discussion 214–223
• 101 Arakawa Y, Kikuta K, Hojo M , et al. Milrinone reduces cerebral vasospasm after subarachnoid hemorrhage of WFNS grade IV or V. Neurol Med Chir (Tokyo) 2004; 44 (8) 393-400 , discussion 401
• 102 Arakawa Y, Kikuta K, Hojo M, Goto Y, Ishii A, Yamagata S. Milrinone for the treatment of cerebral vasospasm after subarachnoid hemorrhage: report of seven cases. Neurosurgery 2001; 48 (4) 723-728 , discussion 728–730
• 103 Fraticelli AT, Cholley BP, Losser MR, Saint Maurice JP, Payen D. Milrinone for the treatment of cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Stroke 2008; 39 (3) 893-898
• 104 Westhout FD, Nwagwu CI. Intra-arterial verapamil-induced seizures: case report and review of the literature. Surg Neurol 2007; 67 (5) 483-486 , discussion 486
• 105 Apostolides PJ, Greene KA, Zabramski JM, Fitzgerald JW, Spetzler RF. Intra-aortic balloon pump counterpulsation in the management of concomitant cerebral vasospasm and cardiac failure after subarachnoid hemorrhage: technical case report. Neurosurgery 1996; 38 (5) 1056-1059 , discussion 1059–1060
• 106 Nussbaum ES, Sebring LA, Ganz WF, Madison MT. Intra-aortic balloon counterpulsation augments cerebral blood flow in the patient with cerebral vasospasm: a xenon-enhanced computed tomography study. Neurosurgery 1998; 42 (1) 206-213
• 107 Appelboom G, Strozyk D, Hwang BY , et al. Bedside use of a dual aortic balloon occlusion for the treatment of cerebral vasospasm. Neurocrit Care 2010; 13 (3) 385-388
• 108 Schellinger PD, Shuaib A, Köhrmann M , et al; for the SENTIS Trial Investigators. Reduced mortality and severe disability rates in the SENTIS Trial. AJNR Am J Neuroradiol 2013; (Jul): 4
• 109 Shuaib A, Bornstein NM, Diener HC , et al; SENTIS Trial Investigators. Partial aortic occlusion for cerebral perfusion augmentation: safety and efficacy of NeuroFlo in Acute Ischemic Stroke trial. Stroke 2011; 42 (6) 1680-1690
• 110 Chun-jing H, Shan O, Guo-dong L, Hao-xiong N, Yi-ran L, Ya-ping F. Effect of cervical sympathetic block on cerebral vasospasm after subarachnoid hemorrhage in rabbits. Acta Cir Bras 2013; 28 (2) 89-93
• 111 Treggiari MM, Romand JA, Martin JB, Reverdin A, Rüfenacht DA, de Tribolet N. Cervical sympathetic block to reverse delayed ischemic neurological deficits after aneurysmal subarachnoid hemorrhage. Stroke 2003; 34 (4) 961-967